Basic Information
| RNALocate ID: | RLID-D:11000363 |
| RNA Symbol: | hsa-miR-143-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-143-3p |
| RNA ID: | miRBase:MIMAT0000435 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001787 | Cytoplasm | Luminal cells|Stromal cells | 29073169 |
| RLID:01001788 | Nucleus | Stromal cells | 29073169 |
| RLID:11001797 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11001798 | Exosome | EBV- and KSHV-negative Burkitt lymphoma cell line (Bjab)|EBV-infected lymphoblastoid cell line (LCL)|KSHV-infected lymphoma cell lines (BCBL-1|TY-1) | 27611973 |
| RLID:11001799 | Exosome | Breast milk | 22211110 |
| RLID:11001800 | Exosome | Brain tissue | 23382797 |
| RLID:11001801 | Exosome | Plasma | 23663360 |
| RLID:11001802 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11001803 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11001804 | Exosome | Serum | 25349172 |
| RLID:11001805 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11001806 | Extracellular vesicle | Human umbilical vein endothelial cells | 22327366 |
| RLID:11001807 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001808 | Microvesicle | Plasma | 23077538 |
| RLID-D:11000085 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Mast cells|Saliva |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-143-3p | Diffuse large b cell lymphoma | MNDR-E-MI-14258 |
| MNDR | hsa-miR-143-3p | Splenic marginal zone lymphoma | MNDR-E-MI-14259 |
| MNDR | hsa-miR-143-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-14260 |
| MNDR | hsa-miR-143-3p | Colorectal adenoma | MNDR-E-MI-14261 |
| MNDR | hsa-miR-143-3p | Oral squamous cell carcinoma | MNDR-E-MI-14262 |
| MNDR | hsa-miR-143-3p | Large cell neuroendocrine cancer | MNDR-E-MI-14263 |
| MNDR | hsa-miR-143-3p | Medulloblastoma | MNDR-E-MI-14264 |
| MNDR | hsa-miR-143-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-14265 |
| MNDR | hsa-miR-143-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-14266 |
| MNDR | hsa-miR-143-3p | Lymphoma | MNDR-E-MI-14267 |
| MNDR | hsa-miR-143-3p | Lymphoma non-hodgkin | MNDR-E-MI-14268 |
| MNDR | hsa-miR-143-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-14269 |
| MNDR | hsa-miR-143-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-14270 |
| MNDR | hsa-miR-143-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-14271 |
| MNDR | hsa-miR-143-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-14272 |
| MNDR | hsa-miR-143-3p | Her2-receptor positive breast cancer | MNDR-E-MI-14273 |
| MNDR | hsa-miR-143-3p | Breast cancer luminal | MNDR-E-MI-14274 |
| MNDR | hsa-miR-143-3p | Niemann-pick disease type c | MNDR-E-MI-14275 |
| MNDR | hsa-miR-143-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-14276 |
| MNDR | hsa-miR-143-3p | Colorectal carcinoma | MNDR-E-MI-14277 |
| MNDR | hsa-miR-143-3p | Neurofibromatosis 1 | MNDR-E-MI-14278 |
| MNDR | hsa-miR-143-3p | Bone metastasis of prostate cancer | MNDR-E-MI-14279 |
| MNDR | hsa-miR-143-3p | B-cell malignancy | MNDR-E-MI-14280 |
| MNDR | hsa-miR-143-3p | Gastric cancer | MNDR-E-MI-14281 |
| MNDR | hsa-miR-143-3p | Gastric lymphoma | MNDR-E-MI-14282 |
| MNDR | hsa-miR-143-3p | Alzheimer disease | MNDR-E-MI-14283 |
| MNDR | hsa-miR-143-3p | Intracranial aneurysm | MNDR-E-MI-14284 |
| MNDR | hsa-miR-143-3p | Bladder cancer | MNDR-E-MI-14285 |
| MNDR | hsa-miR-143-3p | Esophageal carcinoma | MNDR-E-MI-14286 |
| MNDR | hsa-miR-143-3p | Dysautonomia familial | MNDR-E-MI-14287 |
| MNDR | hsa-miR-143-3p | Duchenne muscular dystrophy | MNDR-E-MI-14288 |
| MNDR | hsa-miR-143-3p | Head and neck cancer | MNDR-E-MI-14289 |
| MNDR | hsa-miR-143-3p | Leukemia | MNDR-E-MI-14290 |
| MNDR | hsa-miR-143-3p | Huntington disease | MNDR-E-MI-14291 |
| MNDR | hsa-miR-143-3p | Chorea | MNDR-E-MI-14292 |
| MNDR | hsa-miR-143-3p | Cardiovascular disease | MNDR-E-MI-14293 |
| MNDR | hsa-miR-143-3p | Lung cancer | MNDR-E-MI-14294 |
| MNDR | hsa-miR-143-3p | Parkinson disease | MNDR-E-MI-14295 |
| MNDR | hsa-miR-143-3p | Niemann-pick disease | MNDR-E-MI-14296 |
| MNDR | hsa-miR-143-3p | Colonic adenomas | MNDR-E-MI-14297 |
| MNDR | hsa-miR-143-3p | Basal-like breast cancer | MNDR-E-MI-14298 |
| MNDR | hsa-miR-143-3p | Cancer | MNDR-E-MI-14299 |
| MNDR | hsa-miR-143-3p | Squamous cell carcinoma | MNDR-E-MI-14300 |
| MNDR | hsa-miR-143-3p | Vascular diseases | MNDR-E-MI-14301 |
| MNDR | hsa-miR-143-3p | Pituitary neoplasms | MNDR-E-MI-14302 |
| MNDR | hsa-miR-143-3p | Pancreatic cancer | MNDR-E-MI-14303 |
| MNDR | hsa-miR-143-3p | Malignant melanoma | MNDR-E-MI-14304 |
| MNDR | hsa-miR-143-3p | Atherosclerosis | MNDR-E-MI-14305 |
| MNDR | hsa-miR-143-3p | Rectum adenocarcinoma | MNDR-E-MI-14306 |
| MNDR | hsa-miR-143-3p | Nephroblastoma | MNDR-E-MI-14307 |
| MNDR | hsa-miR-143-3p | Colon cancer | MNDR-E-MI-14308 |
| MNDR | hsa-miR-143-3p | Colon adenocarcinoma | MNDR-E-MI-14309 |
| MNDR | hsa-miR-143-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-14310 |
| MNDR | hsa-miR-143-3p | Ovarian cancer | MNDR-E-MI-14311 |
| MNDR | hsa-miR-143-3p | Prostate adenocarcinoma | MNDR-E-MI-14312 |
| MNDR | hsa-miR-143-3p | Kidney cancer | MNDR-E-MI-14313 |
| MNDR | hsa-miR-143-3p | Carcinoma ductal breast | MNDR-E-MI-14314 |
| MNDR | hsa-miR-143-3p | Glioblastoma | MNDR-E-MI-14315 |
| MNDR | hsa-miR-143-3p | Glioma | MNDR-E-MI-14316 |
| MNDR | hsa-miR-143-3p | Chordoma | MNDR-E-MI-14317 |
| MNDR | hsa-miR-143-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-14318 |
| MNDR | hsa-miR-143-3p | Osteosarcoma | MNDR-E-MI-14319 |
| MNDR | hsa-miR-143-3p | Ewing sarcoma family tumor | MNDR-E-MI-14320 |
| MNDR | hsa-miR-143-3p | Liposarcoma | MNDR-E-MI-14321 |
| MNDR | hsa-miR-143-3p | Peripheral vascular disease | MNDR-E-MI-14322 |
| MNDR | hsa-miR-143-3p | Inclusion body myositis | MNDR-E-MI-14323 |
| MNDR | hsa-miR-143-3p | Breast carcinoma | MNDR-E-MI-14324 |
| MNDR | hsa-miR-143-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-14325 |
| MNDR | hsa-miR-143-3p | Meningioma | MNDR-E-MI-14326 |
| MNDR | hsa-miR-143-3p | Liver cancer | MNDR-E-MI-14327 |
| MNDR | hsa-miR-143-3p | Uterine cancer | MNDR-E-MI-14328 |
| MNDR | hsa-miR-143-3p | Gastric adenocarcinoma | MNDR-E-MI-14329 |
| MNDR | hsa-miR-143-3p | Cervical squamous cell carcinoma | MNDR-E-MI-14330 |
| MNDR | hsa-miR-143-3p | Pituitary adenoma | MNDR-E-MI-14331 |
| MNDR | hsa-miR-143-3p | Lung squamous cell carcinoma | MNDR-E-MI-14332 |
| MNDR | hsa-miR-143-3p | Lung adenocarcinoma | MNDR-E-MI-14333 |
| MNDR | hsa-miR-143-3p | Thyroid carcinoma | MNDR-E-MI-14334 |
| MNDR | hsa-miR-143-3p | Ovarian carcinoma | MNDR-E-MI-14335 |
| MNDR | hsa-miR-143-3p | Bladder urothelial carcinoma | MNDR-E-MI-14336 |
| MNDR | hsa-miR-143-3p | Bladder carcinoma | MNDR-E-MI-14337 |
| MNDR | hsa-miR-143-3p | Pancreatic adenocarcinoma | MNDR-E-MI-14338 |
| MNDR | hsa-miR-143-3p | Cervical cancer | MNDR-E-MI-14339 |
| MNDR | hsa-miR-143-3p | Carcinoma renal cell | MNDR-E-MI-14340 |
| MNDR | hsa-miR-143-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-14341 |
| MNDR | hsa-miR-143-3p | Clear cell renal cell carcinoma | MNDR-E-MI-14342 |
| MNDR | hsa-miR-143-3p | Chromophobe renal cell carcinoma | MNDR-E-MI-14343 |
| MNDR | hsa-miR-143-3p | Large cell carcinoma | MNDR-E-MI-14344 |
| MNDR | hsa-miR-143-3p | Cholangiocarcinoma | MNDR-E-MI-14345 |
| MNDR | hsa-miR-143-3p | Gallbladder carcinoma | MNDR-E-MI-14346 |
| MNDR | hsa-miR-143-3p | Esophageal cancer | MNDR-E-MI-14347 |
| MNDR | hsa-miR-143-3p | Lung small cell carcinoma | MNDR-E-MI-14348 |
| MNDR | hsa-miR-143-3p | Encephalopathy bovine spongiform | MNDR-E-MI-14349 |
| MNDR | hsa-miR-143-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-14350 |
| MNDR | hsa-miR-143-3p | Uveal melanoma | MNDR-E-MI-14351 |
| MNDR | hsa-miR-143-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-14352 |
| MNDR | hsa-miR-143-3p | Fibromyalgia | MNDR-E-MI-14353 |
| MNDR | hsa-miR-143-3p | Adenoma | MNDR-E-MI-14354 |
| MNDR | hsa-miR-143-3p | Breast invasive carcinoma | MNDR-E-MI-14355 |
| MNDR | hsa-miR-143-3p | Cerebrovascular disease | MNDR-E-MI-14356 |
| MNDR | hsa-miR-143-3p | Hepatocellular carcinoma | MNDR-E-MI-14357 |
| MNDR | hsa-miR-143-3p | B-cell lymphoma | MNDR-E-MI-14358 |
| MNDR | hsa-miR-143-3p | Rheumatoid arthritis | MNDR-E-MI-14359 |
| MNDR | hsa-miR-143-3p | T-cell leukemia | MNDR-E-MI-14360 |
| MNDR | hsa-miR-143-3p | Chronic kidney disease | MNDR-E-MI-14361 |
| MNDR | hsa-miR-143-3p | Barrett's adenocarcinoma | MNDR-E-MI-14362 |
| MNDR | hsa-miR-143-3p | Chronic fatigue syndrome | MNDR-E-MI-14363 |
| MNDR | hsa-miR-143-3p | Hodgkin lymphoma | MNDR-E-MI-14364 |
| MNDR | hsa-miR-143-3p | Burkitt lymphoma | MNDR-E-MI-14365 |
| MNDR | hsa-miR-143-3p | Dementia vascular | MNDR-E-MI-14366 |
| MNDR | hsa-miR-143-3p | Tonsil cancer | MNDR-E-MI-14367 |
| MNDR | hsa-miR-143-3p | Neuromyelitis optica | MNDR-E-MI-14368 |
| MNDR | hsa-miR-143-3p | Psoriasis | MNDR-E-MI-14369 |
| MNDR | hsa-miR-143-3p | Degenerative disc disease | MNDR-E-MI-14370 |
| MNDR | hsa-miR-143-3p | Acute myelocytic leukemia | MNDR-E-MI-14371 |
| MNDR | hsa-miR-143-3p | Colorectal cancer | MNDR-E-MI-14372 |
| MNDR | hsa-miR-143-3p | Nasopharynx carcinoma | MNDR-E-MI-14373 |
| MNDR | hsa-miR-143-3p | Multiple myeloma | MNDR-E-MI-14374 |
| MNDR | hsa-miR-143-3p | Acute lymphoblastic leukemia | MNDR-E-MI-14375 |
| MNDR | hsa-miR-143-3p | Obesity | MNDR-E-MI-14376 |
| MNDR | hsa-miR-143-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-14377 |
| MNDR | hsa-miR-143-3p | Uterine cervical neoplasms | MNDR-E-MI-14378 |
| MNDR | hsa-miR-143-3p | Fever | MNDR-E-MI-14379 |
| MNDR | hsa-miR-143-3p | Nasopharyngeal cancer | MNDR-E-MI-14380 |
| MNDR | hsa-miR-143-3p | Prostatic neoplasms | MNDR-E-MI-14381 |
| MNDR | hsa-miR-143-3p | Sleep deprivation | MNDR-E-MI-14382 |
| MNDR | hsa-miR-143-3p | Epstein-barr virus infections | MNDR-E-MI-14383 |
| MNDR | hsa-miR-143-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-14384 |
| MNDR | hsa-miR-143-3p | Pituitary acth hypersecretion | MNDR-E-MI-14385 |
| MNDR | hsa-miR-143-3p | Stroke lacunar | MNDR-E-MI-14386 |
| MNDR | hsa-miR-143-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-14387 |
| MNDR | hsa-miR-143-3p | Barrett's carcinogenesis | MNDR-E-MI-14388 |
| MNDR | hsa-miR-143-3p | Breast cancer her3+ negative | MNDR-E-MI-14389 |
| MNDR | hsa-miR-143-3p | Duke C | MNDR-E-MI-14390 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC3 | Homo sapiens | RR00023590 |
TOP